#1 Clinical Trials Search in Europe

Explore popular drugs in clinical trials

Check which drugs are currently being frequently studied.

See also our rare diseases glossary and popular diseases list.

Starting by letter

To open the drugs glossary, select a letter from the list below.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All drugs

Most popular drugs

The list below features the most popular substances currently involved in ongoing clinical trials.

Drug Trials
Pembrolizumab 462
Sodium Chloride 431
Carboplatin 345
Cisplatin 287
Paclitaxel 263
Fluorouracil 238
Oxaliplatin 229
Nivolumab 217
Dexamethasone 211
Rituximab 201
Cyclophosphamide 191
Durvalumab 169
Bevacizumab 168
Capecitabine 160
Paracetamol 160
Atezolizumab 147
Docetaxel 133
Prednisone 129
Tocilizumab 126
Prednisolone 125
Mycophenolate Mofetil 122
Gemcitabine 122
Doxorubicin Hydrochloride 118
Venetoclax 118
Pemetrexed 117
Etoposide 116
Infliximab 102
Lenalidomide 102
Semaglutide 96
Acetylsalicylic Acid 94
Ipilimumab 91
Folinic Acid 90
Placebo 89
Paclitaxel Albumin-Bound 85
Calcium Folinate 83
Daratumumab 83
Cytarabine 80
Fludarabine Phosphate 80
Methotrexate 79
Letrozole 77
Dapagliflozin 76
Bortezomib 75
Gemcitabine Hydrochloride 73
Olaparib 72
Obinutuzumab 68
Tacrolimus 67
Lenvatinib 67
Azacitidine 67
Trastuzumab 66
Cetuximab 65
Fulvestrant 64
Irinotecan 63
Irinotecan Hydrochloride Trihydrate 62
Methylprednisolone 59
Temozolomide 59
Cemiplimab 57
Vincristine Sulfate 57
Trastuzumab Deruxtecan 53
Apixaban 53
Enzalutamide 52
Lidocaine Hydrochloride Monohydrate 52
Amoxicillin 51
Betamethasone Sodium Phosphate 50
Ribociclib 49
Dexamethasone Sodium Phosphate 49
Codeine Phosphate 49
Hydrocortisone 48
Exemestane 48
Lidocaine Hydrochloride 48
Buclizine Hydrochloride 47
Empagliflozin 47
Anastrozole 47
Adalimumab 47
Potassium Chloride 46
Clavulanic Acid 45
Pomalidomide 44
Tenofovir Alafenamide 44
Pertuzumab 44
Oxygen 44
Clopidogrel 43
Doxorubicin 43
Abemaciclib 43
Ibrutinib 43
Rivaroxaban 42
Ruxolitinib 42
Propofol 42
Cyclophosphamide Monohydrate 41
Trimethoprim 41
Atorvastatin 41
Sulfamethoxazole 41
Emtricitabine 40
Palbociclib 40
Ropivacaine Hydrochloride 40
Metformin Hydrochloride 40
Bendamustine Hydrochloride 40
Carfilzomib 40
Cabozantinib 40
Linezolid 39
Dostarlimab 38
Acalabrutinib 38

New drugs in trials

The list below features the new substances involved to ongoing clinical trials.

#1 VMX-C001

Clinical trials are studying VMX-C001 in people who take a Factor Xa direct oral anticoagulant and need urgent surgery or another high-bleeding-risk procedure.

3 months ago
#2 LIPASE

Clinical trials are investigating LIPASE, including a new lipase product compared with pancrelipase.

3 months ago
#3 TRIACYLGLYCEROL LIPASE

Clinical trials of TRIACYLGLYCEROL LIPASE are studying a new lipase treatment in adults with exocrine pancreatic insufficiency.

3 months ago
#4 IMA401

Clinical trials are investigating IMA401 in patients with recurrent and/or refractory solid tumors.

3 months ago
#5 ALLERGEN EXTRACTS

Clinical trials are studying BLOMIA TROPICALIS POLYMERIZED EXTRACT as part of a vaccine for dust mite and Blomia tropicalis allergy.

3 months ago
#6 AUR200

Clinical trials are investigating AUR200 in people with generalized myasthenia gravis.

3 months ago

Drugs starting by y

  • 2 

    YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)

    ,

    Clinical trials are studying YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED) to see how well yellow fever vaccination works and how the immune system responds. The trials include adults and compare different vaccine routes or compare an investigational vaccine with a control vaccine. They mainly measure immune response and skin immune cells after vaccination.

    Related diseases and areas:

  • 1 

    YELLOW FEVER VIRUS, STRAIN VYF-247, LIVE

    ,

    Clinical trials are studying YELLOW FEVER VIRUS, STRAIN VYF-247, LIVE in adults to compare it with an existing yellow fever vaccine. The main goal is to check immune response, especially seroconversion, in people who have not had yellow fever vaccine before. The study is authorized and is being done in Europe and Asia.

    Related diseases and areas:

  • 1 

    YL201

    ,

    Clinical trials are investigating YL201 in people with advanced solid tumors. These studies are looking at safety, dose limits, and early signs of anti-tumor activity when YL201 is given with atezolizumab. The trial is in Phase 1 and is enrolling adults with advanced solid tumors.

  • 1 

    YOHIMBINE HYDROCHLORIDE

    ,

    Clinical trials investigating YOHIMBINE HYDROCHLORIDE are looking at how it may affect stress-related behavior and decision-making. The available study involved military personnel and tested whether it changes moral judgment during an acute stress response. The trial focused on study outcomes such as choice patterns and decision-making errors.

  • 3 

    Yttrium-90

    ,

    Clinical trials investigating Yttrium-90 are studying new treatment approaches in people with certain cancers, including lymphoma and neuroendocrine tumors. These studies look at safety, tolerability, dose, and how well the treatment works. The trials involve patients with non-Hodgkin lymphoma, CNS lymphoma, and gastrointestinal neuroendocrine tumors.

    Related diseases and areas: